Board of Directors
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis
Board of Directors
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis
Key IP generated from Murali and Yu Labs
Published patents executed internationally
Exclusive, worldwide rights to IP licensed from Cedars Sinai Medical Center
Pub #
KROS 401
PCT/US2016/035318
KROS 401
PCT/US2015/050906
KROS 401
PCT/US2019/045478
KROS 401
PCT/US2020/045570
KROS 401
PCT/US2017/037558
Title
Methods And Use Of Compounds That Bind To RELA Of NF-KB
Compositions And Methods For Treating Fibrosis
Compositions And Methods For Treating Cancer And Autoimmune Diseases
Method Of Generating Activated T Cells For Cancer Therapy
Sensitization Of Tumors To Therapies Through Endoglin Antagonism
Key IP generated from Murali and Yu Labs
Published patents executed internationally
Exclusive, worldwide rights to IP licensed from Cedars Sinai Medical Center
Pub #
KROS 401
PCT/US2016/035318
KROS 401
PCT/US2015/050906
KROS 401
PCT/US2019/045478
KROS 401
PCT/US2020/045570
KROS 401
PCT/US2017/037558
Title
Methods And Use Of Compounds That Bind To RELA Of NF-KB
Compositions And Methods For Treating Fibrosis
Compositions And Methods For Treating Cancer And Autoimmune Diseases
Method Of Generating Activated T Cells For Cancer Therapy
Sensitization Of Tumors To Therapies Through Endoglin Antagonism
Related links
Technologies
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Pipleine
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Investors
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Key IP generated from Murali and Yu Labs
Published patents executed internationally
Exclusive, worldwide rights to IP licensed from Cedars Sinai Medical Center
Pub #
KROS 401
PCT/US2016/035318
KROS 401
PCT/US2015/050906
KROS 401
PCT/US2019/045478
KROS 401
PCT/US2020/045570
KROS 401
PCT/US2017/037558
Title
Methods And Use Of Compounds That Bind To RELA Of NF-KB
Compositions And Methods For Treating Fibrosis
Compositions And Methods For Treating Cancer And Autoimmune Diseases
Method Of Generating Activated T Cells For Cancer Therapy
Sensitization Of Tumors To Therapies Through Endoglin Antagonism
Connect with us on social
